Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1

Overview of attention for article published in Nature Genetics, March 2002

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 2 X users

patent: 52 patents

Readers on

mendeley: 426 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

So far, Altmetric has seen 52 patents that reference this research output.

COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS

Application EP-4706689-A2

European Patent Office

11 Mar 2026

MINIGENE CASSETTES, RECOMBINANT POLYNUCLEOTIDES, AND METHODS OF THEIR USE

Application WO-2025054363-A1

World Intellectual Property Organisation (WIPO)

13 Mar 2025

COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY

Application WO-2025035143-A1

World Intellectual Property Organisation (WIPO)

13 Feb 2025

Compositions and methods for detection of SMN protein in a subject and treatment of a…

Grant US-12013403-B2

United States of America

18 Jun 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 48 additional patents.